دورية أكاديمية

Effects of a combined exercise and dietary intervention on body composition, physical functioning and fatigue in patients with ovarian cancer: results of the PADOVA trial.

التفاصيل البيبلوغرافية
العنوان: Effects of a combined exercise and dietary intervention on body composition, physical functioning and fatigue in patients with ovarian cancer: results of the PADOVA trial.
المؤلفون: Kenkhuis MF; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Stelten S; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Hartman YA; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Brouwer CG; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Ten Tusscher MR; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., van Lonkhuijzen LR; Obstetrics and Gynaecology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Kenter GG; Obstetrics and Gynaecology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Obstetrics and Gynaecology, Cancer Center Amsterdam, Center for Gynaecologic Oncology Amsterdam (CGOA), Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Gynaecology, Center for Gynaecologic Oncology Amsterdam (CGOA), The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van Driel WJ; Gynaecology, Center for Gynaecologic Oncology Amsterdam (CGOA), The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Winkels RM; Human Nutrition and Health, Wageningen University and Research, Wageningen, The Netherlands., Bekkers RL; Department of Obstetrics and Gynaecology, Grow school for oncology and reproduction, Maastricht University, Maastricht, The Netherlands.; Department of Gynecology, Catharina Hospital, Eindhoven, The Netherlands.; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Ottevanger NP; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Hoedjes M; CoRPS-Center of Research on Psychological and Somatic Disorders, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands., Buffart LM; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands. laurien.buffart@radboudumc.nl.
المصدر: British journal of cancer [Br J Cancer] 2024 Jul; Vol. 131 (1), pp. 101-109. Date of Electronic Publication: 2024 May 08.
نوع المنشور: Journal Article; Randomized Controlled Trial
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
أسماء مطبوعة: Publication: 2002- : London : Nature Publishing Group on behalf of Cancer Research UK
Original Publication: London, Lewis.
مواضيع طبية MeSH: Fatigue*/etiology , Ovarian Neoplasms*/diet therapy , Ovarian Neoplasms*/complications , Body Composition*, Humans ; Female ; Middle Aged ; Exercise/physiology ; Aged ; Exercise Therapy/methods ; Adult
مستخلص: Background: Guidelines recommend to include exercise and dietary advice in standard care for patients with cancer, based on evidence primarily derived from patients with breast cancer. Its applicability to patients with ovarian cancer is uncertain due to differences in patient characteristics and treatments. The PADOVA trial examined the effectiveness of a combined exercise and dietary intervention on fat-free mass (FFM), physical functioning, and fatigue.
Methods: In total, 81 patients with ovarian cancer were randomised to the exercise and dietary intervention (n = 40) or control (n = 41) group. Measurements were performed before chemotherapy, after chemotherapy, and 12 weeks later. FFM was assessed by bioelectrical impedance analysis, and physical functioning and fatigue were assessed using questionnaires. Intervention effects were assessed on an intention-to-treat basis using linear mixed models.
Results: FFM and physical functioning increased, and fatigue decreased significantly over time in both groups. No significant difference between the groups were found for FFM (β = -0.5 kg; 95% CI = -3.2; 2.1), physical functioning (β = 1.4; 95% CI = -5.4; 8.3) and fatigue (β = 0.7; 95% CI = -1.5; 2.8).
Conclusions: During treatment, both groups improved in FFM, physical functioning, and fatigue. The intervention group, however, did not demonstrate additional benefits compared to the control group. This highlights the need for caution when extrapolating findings from different cancer populations to patients with ovarian cancer.
(© 2024. The Author(s), under exclusive licence to Springer Nature Limited.)
References: Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71:209–49. (PMID: 33538338)
Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14:9–32. (PMID: 28443200536518710.20892/j.issn.2095-3941.2016.0084)
Ledermann J, Raja F, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24:vi24–vi32. (PMID: 2407866010.1093/annonc/mdt333)
Rutten IJ, van Dijk DP, Kruitwagen RF, Beets‐Tan RG, Olde Damink SW, Van Gorp T. Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients. J Cachexia Sarcopenia Muscle. 2016;7:458–66. (PMID: 27030813478225110.1002/jcsm.12107)
Fearon KC, Barber MD, Moses AG. The cancer cachexia syndrome. Surg Oncol Clin North Am. 2001;10:109–26. (PMID: 10.1016/S1055-3207(18)30088-7)
Kampshoff CS, Chinapaw MJ, Brug J, Twisk JW, Schep G, Nijziel MR, et al. Randomized controlled trial of the effects of high intensity and low-to-moderate intensity exercise on physical fitness and fatigue in cancer survivors: results of the Resistance and Endurance exercise After ChemoTherapy (REACT) study. BMC Med. 2015;13:275. (PMID: 26515383462593710.1186/s12916-015-0513-2)
van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, et al. Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES Randomized Clinical Trial. J Clin Oncol. 2015;33:1918–27. (PMID: 2591829110.1200/JCO.2014.59.1081)
Sweegers MG, Altenburg TM, Brug J, May AM, Van Vulpen JK, Aaronson NK, et al. Effects and moderators of exercise on muscle strength, muscle function and aerobic fitness in patients with cancer: a meta-analysis of individual patient data. Br J Sports Med. 2019;53:812. (PMID: 3018132310.1136/bjsports-2018-099191)
Van Vulpen JK, Sweegers MG, Peeters PH, Courneya KS, Newton RU, Aaronson NK, et al. Moderators of exercise effects on cancer-related fatigue: a meta-analysis of individual patient data. Med Sci Sports Exerc. 2020;52:303. (PMID: 31524827696254410.1249/MSS.0000000000002154)
McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. Cmaj. 2006;175:34–41. (PMID: 16818906148275910.1503/cmaj.051073)
Padilha CS, Marinello PC, Galvao DA, Newton RU, Borges FH, Frajacomo F, et al. Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis. J Cancer Surviv. 2017;11:339–49. (PMID: 2805425510.1007/s11764-016-0592-x)
Cohen CW, Fontaine KR, Arend RC, Alvarez RD, Leath CA III A ketogenic diet reduces central obesity and serum insulin in women with ovarian or endometrial cancer. J Nutr. 2018;148:1253–60. (PMID: 30137481849651610.1093/jn/nxy119)
Demark-Wahnefried W, Morey MC, Sloane R, Snyder DC, Miller PE, Hartman TJ, et al. Reach out to enhance wellness home-based diet-exercise intervention promotes reproducible and sustainable long-term improvements in health behaviors, body weight, and physical functioning in older, overweight/obese cancer survivors. J Clin Oncol. 2012;30:2354–61. (PMID: 22614994367569310.1200/JCO.2011.40.0895)
Johns DJ, Hartmann-Boyce J, Jebb SA, Aveyard P, Group BWMR. Diet or exercise interventions vs combined behavioral weight management programs: a systematic review and meta-analysis of direct comparisons. J Acad Nutr Diet. 2014;114:1557–68. (PMID: 25257365418000210.1016/j.jand.2014.07.005)
Ligibel JA, Bohlke K, May AM, Clinton SK, Demark-Wahnefried W, Gilchrist SC, et al. Exercise, diet, and weight management during cancer treatment: ASCO guideline. J Clin Oncol. 2022;40:2491–507. (PMID: 3557650610.1200/JCO.22.00687)
Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62:243–74. (PMID: 2253923810.3322/caac.21142)
Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36:11–48. (PMID: 2763783210.1016/j.clnu.2016.07.015)
Newton MJ, Hayes SC, Janda M, Webb PM, Obermair A, Eakin EG, et al. Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study. BMC Cancer. 2011;11:1–9. (PMID: 10.1186/1471-2407-11-389)
Mizrahi D, Broderick C, Friedlander M, Ryan M, Harrison M, Pumpa K, et al. An exercise intervention during chemotherapy for women with recurrent ovarian cancer: a feasibility study. Int J Gynecol Cancer. 2015;25:985–92.
von Gruenigen VE, Frasure HE, Kavanagh MB, Lerner E, Waggoner SE, Courneya KS. Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy. Gynecol Oncol. 2011;122:328–33. (PMID: 10.1016/j.ygyno.2011.04.043)
Maurer T, Belau MH, von Grundherr J, Schlemmer Z, Patra S, Becher H, et al. Randomised controlled trial testing the feasibility of an exercise and nutrition intervention for patients with ovarian cancer during and after first-line chemotherapy (BENITA-study). BMJ Open. 2022;12:e054091. (PMID: 35197344886731310.1136/bmjopen-2021-054091)
Jones TL, Sandler CX, Spence RR, Hayes SC. Physical activity and exercise in women with ovarian cancer: a systematic review. Gynecol Oncol. 2020;158:803–11. (PMID: 3261640210.1016/j.ygyno.2020.06.485)
Smits A, Smits E, Lopes A, Das N, Hughes G, Talaat A, et al. Body mass index, physical activity and quality of life of ovarian cancer survivors: time to get moving? Gynecol Oncol. 2015;139:148–54. (PMID: 2629165010.1016/j.ygyno.2015.08.005)
Stevinson C, Faught W, Steed H, Tonkin K, Ladha AB, Vallance JK, et al. Associations between physical activity and quality of life in ovarian cancer survivors. Gynecol Oncol. 2007;106:244–50. (PMID: 1749367110.1016/j.ygyno.2007.03.033)
Stelten S, Hoedjes M, Kenter GG, Kampman E, Huijsmans RJ, van Lonkhuijzen LR, et al. Rationale and study protocol of the Physical Activity and Dietary intervention in women with OVArian cancer (PADOVA) study: a randomised controlled trial to evaluate effectiveness of a tailored exercise and dietary intervention on body composition, physical function and fatigue in women with ovarian cancer undergoing chemotherapy. BMJ Open. 2020;10:e036854. (PMID: 33148722764350310.1136/bmjopen-2020-036854)
Wereld Kanker Onderzoeks Fonds. Gezond leven Na kanker. 2017. Retrieved from: https://www.wkof.nl/gezond-leven/verklein-de-kans-op-kanker/de-aanbevelingen-voor-minder-kans-op-kanker/ on 15th of November 2023.
De Backer IC, Schep G, Hoogeveen A, Vreugdenhil G, Kester AD, van Breda E. Exercise testing and training in a cancer rehabilitation program: the advantage of the steep ramp test. Arch Phys Med Rehabil. 2007;88:610–6. (PMID: 1746673010.1016/j.apmr.2007.02.013)
Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377–81. (PMID: 715489310.1249/00005768-198205000-00012)
World Cancer Research Fund/American Institute for Cancer Research. Diet, nutrition, physical activity and cancer: a global perspective. Continuous Update Project Expert Report 2018. Available at dietandcancerreport.org.
Miller WR, Rollnick S. Ten things that motivational interviewing is not. Behav Cogn Psychother. 2009;37:129–40. (PMID: 1936441410.1017/S1352465809005128)
Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia: protein, amino acid metabolism and therapy. Curr Opin Clin Nutr Metab Care. 2009;12:86. (PMID: 19057193276031510.1097/MCO.0b013e32831cef8b)
Bandura A. Social foundations of thought and action: a social cognitive theory. Englewood Cliffs, NJ: Prentice Hall; 1986.
Stelten S, Ten Tusscher MR, Stuiver MM, Hartman YA, van Lonkhuijzen LR, Kenter GG, et al. Tailoring of exercise and dietary interventions to adverse effects and existing comorbidities in patients with ovarian cancer receiving chemotherapy: a clinical vignettes study among expert physical therapists and dietitians. Disabil Rehabil. 2023;1–8. [Online ahead of print].
Bolanowski M, Nilsson BE. Assessment of human body composition using dual-energy X-ray absorptiometry and bioelectrical impedance analysis. Med Sci Monit: Int Med J Exp Clin Res. 2001;7:1029–33.
Steiner M, Barton R, Singh S, Morgan M. Bedside methods versus dual energy X‐ray absorptiometry for body composition measurement in COPD. Eur Respir J. 2002;19:626–31. (PMID: 1199899010.1183/09031936.02.00279602)
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI: J Natl Cancer Inst. 1993;85:365–76. (PMID: 843339010.1093/jnci/85.5.365)
Smets E, Garssen B, Bonke B, De Haes J. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315–25. (PMID: 763677510.1016/0022-3999(94)00125-O)
Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF, et al. Clinician’s guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122:191–225. (PMID: 2058501310.1161/CIR.0b013e3181e52e69)
Edwards R, McDonnell M. Hand-held dynamometer for evaluating voluntary-muscle function. Lancet. 1974;304:757–8. (PMID: 10.1016/S0140-6736(74)90947-7)
Burns SP, Spanier DE. Break-technique handheld dynamometry: relation between angular velocity and strength measurements. Arch Phys Med Rehabil. 2005;86:1420–6. (PMID: 1600367510.1016/j.apmr.2004.12.041)
Greimel E, Bottomley A, Cull A, Waldenstrom A-C, Arraras J, Chauvenet L, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer. 2003;39:1402–8. (PMID: 1282604310.1016/S0959-8049(03)00307-1)
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scandinavica. 1983;67:361–70. (PMID: 10.1111/j.1600-0447.1983.tb09716.x)
Postma TJ, Aaronson N, Heimans J, Muller M, Hildebrand J, Delattre J-Y, et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer. 2005;41:1135–9. (PMID: 1591123610.1016/j.ejca.2005.02.012)
Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213. (PMID: 274877110.1016/0165-1781(89)90047-4)
Washburn RA, Smith KW, Jette AM, Janney CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993;46:153–62. (PMID: 843703110.1016/0895-4356(93)90053-4)
van Lee L, Feskens EJ, Meijboom S, van Huysduynen EJH, van’t Veer P, de Vries JH, et al. Evaluation of a screener to assess diet quality in the Netherlands. Br J Nutr. 2016;115:517–26. (PMID: 2662807310.1017/S0007114515004705)
van Lee L, Geelen A, van Huysduynen EJ, de Vries JH, van’t Veer P, Feskens EJ. The Dutch Healthy Diet Index (DHD-index): an instrument to measure adherence to the Dutch Guidelines for a Healthy Diet. Nutr J. 2012;11:49. (PMID: 22818824343928910.1186/1475-2891-11-49)
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83. (PMID: 355871610.1016/0021-9681(87)90171-8)
Fairman C, Nilsen TS, Newton RU, Taaffe DR, Spry N, Joseph D, et al. Reporting of resistance training dose, adherence, and tolerance in exercise oncology. 2020;52:315–22.
Stelten S, van Lonkhuijzen L, Hartman Y, van Driel W, Winkels R, Kenter G, et al. Experiences, adherence and satisfaction with a combined exercise and dietary intervention for patients with ovarian cancer undergoing chemotherapy: a mixed-methods study. Gynecol Oncol. 2022;165:619–28. (PMID: 3533767210.1016/j.ygyno.2022.03.011)
Van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, et al. Effect of low-intensity physical activity and moderate-to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol. 2015;33:1918–27. (PMID: 2591829110.1200/JCO.2014.59.1081)
Demark-Wahnefried W, Peterson BL, Winer EP, Marks L, Aziz N, Marcom PK, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2001;19:2381–9. (PMID: 1133131610.1200/JCO.2001.19.9.2381)
Campbell KL, Van Patten CL, Neil SE, Kirkham AA, Gotay CC, Gelmon KA, et al. Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity. J Acad Nutr Diet. 2012;112:559–67. (PMID: 2270970610.1016/j.jada.2011.10.022)
Blauwhoff-Buskermolen S, Versteeg KS, de van der Schueren MA, den Braver NR, Berkhof J, Langius JA, et al. Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer. J Clin Oncol. 2016;34:1339–44. (PMID: 2690357210.1200/JCO.2015.63.6043)
Battaglini C, Bottaro M, Dennehy C, Rae L, Shields E, Kirk D, et al. The effects of an individualized exercise intervention on body composition in breast cancer patients undergoing treatment. Sao Paulo Med J. 2007;125:22–8. (PMID: 175056811101470510.1590/S1516-31802007000100005)
Jones LW, Liang Y, Pituskin EN, Battaglini CL, Scott JM, Hornsby WE, et al. Effect of exercise training on peak oxygen consumption in patients with cancer: a meta‐analysis. Oncologist. 2011;16:112–20. (PMID: 21212429322805210.1634/theoncologist.2010-0197)
Persoon S, ChinAPaw MJ, Buffart LM, Liu RD, Wijermans P, Koene HR, et al. Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: results from the EXIST study. PLoS ONE. 2017;12:e0181313. (PMID: 28727771551907210.1371/journal.pone.0181313)
Bezjak A, Tu D, Bacon M, Osoba D, Zee B, Stuart G, et al. Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study. J Clin Oncol. 2004;22:4595–603. (PMID: 1546678510.1200/JCO.2004.08.080)
Binotto M, Schwartsmann G. Health-related quality of life of breast cancer patients: integrative literature review. Revista Brasileira de Cancerologia. 2020;66.
Chan Y, Ng T, Ngan HY, Wong L. Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: a prospective longitudinal study. Gynecol Oncol. 2003;88:9–16. (PMID: 1250462010.1006/gyno.2002.6849)
Steins Bisschop CN, Courneya KS, Velthuis MJ, Monninkhof EM, Jones LW, Friedenreich C, et al. Control group design, contamination and drop-out in exercise oncology trials: a systematic review. PLoS ONE. 2015;10:e0120996. (PMID: 25815479437687910.1371/journal.pone.0120996)
Stacey FG, James EL, Chapman K, Courneya KS, Lubans DR. A systematic review and meta-analysis of social cognitive theory-based physical activity and/or nutrition behavior change interventions for cancer survivors. J Cancer Surviv. 2015;9:305–38. (PMID: 2543263310.1007/s11764-014-0413-z)
Dekker J, de Rooij M, van der Leeden M. Exercise and comorbidity: the i3-S strategy for developing comorbidity-related adaptations to exercise therapy. Disabil Rehabil. 2016;38:905–9. (PMID: 2617617010.3109/09638288.2015.1066451)
Gaona-Luviano P, Medina-Gaona LA, Magaña-Pérez K. Epidemiology of ovarian cancer. Chin Clin Oncol. 2020;9:47. (PMID: 3264844810.21037/cco-20-34)
Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Women’s Health. 2019;11:287–99.
Sheill G, Guinan E, Brady L, Hevey D, Hussey J. Exercise interventions for patients with advanced cancer: a systematic review of recruitment, attrition, and exercise adherence rates. Palliat Support Care. 2019;17:686–96. (PMID: 3110938310.1017/S1478951519000312)
معلومات مُعتمدة: 2015-7950 KWF Kankerbestrijding (Dutch Cancer Society)
تواريخ الأحداث: Date Created: 20240508 Date Completed: 20240708 Latest Revision: 20240831
رمز التحديث: 20240831
مُعرف محوري في PubMed: PMC11231132
DOI: 10.1038/s41416-024-02694-8
PMID: 38720046
قاعدة البيانات: MEDLINE
الوصف
تدمد:1532-1827
DOI:10.1038/s41416-024-02694-8